Genetic variants of Clostridium difficile have been reported with increasing frequency, but their true incidence is unknown. C. difficile strains have been classified into variant toxinotypes according to variations in the pathogenicity locus encoding the major virulence factors, toxins A and B. Some strains produce an additional toxin, binary toxin CDT. This survey of clinical isolates (153) from patients in a single hospital set out to ascertain the distribution of variant toxinotypes and strains possessing binary toxin genes. A PCR-RFLP-based method of toxinotyping identified 123 (80.4 %) isolates as toxinotype 0, 13 (8.5 %) strains as non-toxigenic and 17 (11.1 %) as belonging to variant toxinotypes. Binary toxin genes were amplified by PCR in nine strains (5.8 %), all of which were variant toxinotypes. Toxin variants of C. difficile are pathogenic and commonly isolated and need to be considered when evaluating new diagnostic testing strategies for C. difficile disease.
al-BarrakA.,
EmbilJ.,
DyckB.,
OleksonK.,
NicollD.,
AlfaM.,
KabaniA.1999; An outbreak of toxin A negative, toxin B positive Clostridium difficile -associated diarrhea in a Canadian tertiary-care hospital. Can Commun Dis Rep 25:65–69
BarbutF.,
LalandeV.,
BurghofferB.,
ThienH. V.,
GrimprelE.,
PetitJ. C.2002; Prevalence and genetic characterization of toxin A variant strains of Clostridium difficile among adults and children with diarrhea in France. J Clin Microbiol 40:2079–2083[CrossRef]
BraunV.,
HundsbergerT.,
LeukelP.,
SauerbornM.,
von Eichel-StreiberC.1996; Definition of the single integration site of the pathogenicity locus in Clostridium difficile
. Gene 181:29–38[CrossRef]
BraunV.,
MehligM.,
MoosM.,
RupnikM.,
KaltB.,
MahonyD. E.,
von Eichel-StreiberC.2000; A chimeric ribozyme in Clostridium difficile combines features of group I introns and insertion elements. Mol Microbiol 36:1447–1459
Camorlinga-PonceM.,
GamboaM.,
BarraganJ. J.,
MunozO.,
FeketyF. R.,
TorresJ. F.1987; Epidemiological aspects of Clostridium difficile in a pediatric hospital and its role in diarrheal disease. Eur J Clin Microbiol 6:542–546[CrossRef]
CarmanR.,
McEllistremM. C.,
GenheimerC. W.,
ZhengL.2003; Iota-like binary toxin producing strains of Clostridium difficile (Cd) associated with an outbreak of severe nosocomial antibiotic-associated diarrhea (ADD. In ASM 103rd general meeting abstract book Washington, DC: abstract C-381p– 188 Washington, DC: American Society for Microbiology;
Chaves-OlarteE.,
FreerE.,
ParraA.,
Guzman-VerriC.,
MorenoE.,
ThelestamM.2003; R-ras glucosylation and transient RhoA activation determine the cytopathic effect produced by toxin B variants from toxin A-negative strains of Clostridium difficile
. J Biol Chem 278:7956–7963[CrossRef]
ClabotsC. R.,
JohnsonS.,
OlsonM. M.,
PetersonL. R.,
GerdingD. N.1992; Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection. J Infect Dis 166:561–567[CrossRef]
CohenS. H.,
TangY. J.,
HansenB.,
SilvaJ.Jr1998; Isolation of a toxin B-deficient mutant strain of Clostridium difficile in a case of recurrent C.difficile -associated diarrhea. Clin Infect Dis 26:410–412[CrossRef]
DepitreC.,
DelméeM.,
AvesaniV.,
L'HaridonR.,
RoelsA.,
PopoffM.,
CorthierG.1993; Serogroup F strains of Clostridium difficile produce toxin B but not toxin A. J Med Microbiol 38:434–441[CrossRef]
GericB.,
RupnikM.,
SambolS. P.,
CarmanR. J.,
GrabnarM.,
GerdingD. N.,
JohnsonS.2003a; The effect of Clostridium difficile binary toxin (CDT) in animals depends upon the animal model. In Program and abstracts of Clostridia Pathogenesis 03 Woods Hole, MA, abstract 12
GericB.,
JohnsonS.,
GerdingD. N.,
GrabnarM.,
RupnikM.2003b; Frequency of binary toxin genes among Clostridium difficile strains that do not produce large clostridial toxins. J Clin Microbiol 41:5227–5232[CrossRef]
JohnsonS.,
AdelmannA.,
ClabotsC. R.,
PetersonL. R.,
GerdingD. N.1989; Recurrences of Clostridium difficile diarrhea not caused by the original infecting organism. J Infect Dis 159:340–343[CrossRef]
JohnsonS.,
KentS. A.,
O'LearyK. J.,
MerriganM. M.,
SambolS. P.,
PetersonL. R.,
GerdingD. N.2001; Fatal pseudomembranous colitis associated with a variant Clostridium difficile strain not detected by toxin A immunoassay. Ann Intern Med 135:434–438[CrossRef]
KaderH. A.,
PiccoliD. A.,
JawadA. F.,
McGowanK. L.,
MallerE. S.1998; Single toxin detection is inadequate to diagnose Clostridium difficile diarrhea in pediatric patients. Gastroenterology 115:1329–1334[CrossRef]
KuijperE. J.,
de WeerdtJ.,
KatoH.,
KatoN.,
van DamA. P.,
van der VormE. R.,
WeelJ.,
van RheenenC.,
DankertJ.2001; Nosocomial outbreak of Clostridium difficile -associated diarrhoea due to a clindamycin-resistant enterotoxin A-negative strain. Eur J Clin Microbiol Infect Dis 20:528–534[CrossRef]
LyerlyD. M.,
NevilleL. M.,
EvansD. T. & 7 other authors; 1998; Multicenter evaluation of the Clostridium difficile TOX A/B TEST. J Clin Microbiol 36:184–190
MekonenE. T.,
GerdingD. N.,
SambolS. P.,
PottingerJ. M.,
PulvirentiJ. J.,
MarshD.,
KockaF. E.,
JohnsonS.2002; Predominance of a single restriction endonuclease analysis group with intrahospital subgroup diversity among Clostridium difficile isolates at two Chicago hospitals. Infect Control Hosp Epidemiol 23:648–652[CrossRef]
O'NeillG. L.,
OgunsolaF. T.,
BrazierJ. S.,
DuerdenB. I.1996; Modification of a PCR ribotyping method for application as a routine typing scheme for Clostridium difficile
. Anaerobe 2:205–209[CrossRef]
PituchH.,
van den BraakN.,
van LeeuwenW.,
van BelkumA.,
MartirosianG.,
Obuch-WoszczatynskiP.,
LuczakM.,
Meisel-MikolajczykF.2001; Clonal dissemination of a toxin-A-negative/toxin-B-positive Clostridium difficile strain from patients with antibiotic-associated diarrhea in Poland. Clin Microbiol Infect 7:442–446[CrossRef]
PopoffM. R.,
RubinE. J.,
GillD. M.,
BoquetP.1988; Actin-specific ADP-ribosyltransferase produced by a Clostridium difficile strain. Infect Immun 56:2299–2306
RupnikM.,
BraunV.,
SoehnF.,
JancM.,
HofstetterM.,
Laufenberg-FeldmannR.,
von Eichel-StreiberC.1997; Characterization of polymorphisms in the toxin A and B genes of Clostridium difficile
. FEMS Microbiol Lett 148:197–202[CrossRef]
RupnikM.,
AvesaniV.,
JancM.,
von Eichel-StreiberC.,
DelméeM.1998; A novel toxinotyping scheme and correlation of toxinotypes with serogroups of Clostridium difficile isolates. J Clin Microbiol 36:2240–2247
RupnikM.,
BrazierJ. S.,
DuerdenB. I.,
GrabnarM.,
StubbsS. L.2001; Comparison of toxinotyping and PCR ribotyping of Clostridium difficile strains and description of novel toxinotypes. Microbiology 147:439–447
SambolS. P.,
MerriganM. M.,
LyerlyD.,
GerdingD. N.,
JohnsonS.2000; Toxin gene analysis of a variant strain of Clostridium difficile that causes human clinical disease. Infect Immun 68:5480–5487[CrossRef]
SpigagliaP.,
MastrantonioP.2002; Molecular analysis of the pathogenicity locus and polymorphism in the putative negative regulator of toxin production (TcdC) among Clostridium difficile clinical isolates. J Clin Microbiol 40:3470–3475[CrossRef]
StubbsS.,
RupnikM.,
GibertM.,
BrazierJ.,
DuerdenB.,
PopoffM.2000; Production of actin-specific ADP-ribosyltransferase (binary toxin) by strains of Clostridium difficile
. FEMS Microbiol Lett 186:307–312[CrossRef]
WilcoxM. H.,
FawleyW. N.,
SettleC. D.,
DavidsonA.1998; Recurrence of symptoms in Clostridium difficile infection–relapse or reinfection?. J Hosp Infect 38:93–100[CrossRef]